Uranium Royalty’s (UROY) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Uranium Royalty (NASDAQ:UROYFree Report) in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a $4.50 target price on the stock.

UROY has been the topic of a number of other research reports. Raymond James Financial upgraded Uranium Royalty from a “market perform” rating to an “outperform” rating in a report on Tuesday, April 21st. Weiss Ratings restated a “hold (c-)” rating on shares of Uranium Royalty in a research note on Tuesday, June 9th. Zacks Research raised Uranium Royalty from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Finally, Wall Street Zen downgraded Uranium Royalty from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $4.50.

Read Our Latest Analysis on UROY

Uranium Royalty Price Performance

Uranium Royalty stock opened at $2.81 on Thursday. Uranium Royalty has a 1-year low of $2.42 and a 1-year high of $5.52. The stock has a market cap of $411.92 million, a PE ratio of 140.57 and a beta of 1.40. The stock’s fifty day moving average is $3.16 and its two-hundred day moving average is $3.69.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Uranium Royalty by 7.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,052,298 shares of the company’s stock valued at $30,406,000 after buying an additional 469,267 shares during the last quarter. CenterBook Partners LP grew its position in shares of Uranium Royalty by 828.7% during the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock worth $15,744,000 after acquiring an additional 3,968,521 shares during the last quarter. Alps Advisors Inc. grew its position in shares of Uranium Royalty by 23.7% during the fourth quarter. Alps Advisors Inc. now owns 3,892,680 shares of the company’s stock worth $13,780,000 after acquiring an additional 745,145 shares during the last quarter. Accordant Advisory Group Inc increased its holdings in shares of Uranium Royalty by 0.8% in the 4th quarter. Accordant Advisory Group Inc now owns 2,470,489 shares of the company’s stock valued at $8,746,000 after acquiring an additional 19,882 shares during the period. Finally, Vident Advisory LLC increased its holdings in shares of Uranium Royalty by 4.7% in the 3rd quarter. Vident Advisory LLC now owns 1,549,782 shares of the company’s stock valued at $6,674,000 after acquiring an additional 69,631 shares during the period. Institutional investors and hedge funds own 24.19% of the company’s stock.

About Uranium Royalty

(Get Free Report)

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.

Further Reading

Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.